ダイト(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4577/E24187 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2022/09/16 | 日証協 | 155,851株 | +37.51% | 94,004株 | +205.68% | 155,815株 | +19.84% | 28,774株 | -4.06% |
2022/09/09 | 日証協 | 113,341株 | +23.05% | 30,752株 | -0.05% | 130,015株 | +25.14% | 29,992株 | +63% |
2022/09/02 | 日証協 | 92,112株 | -6.78% | 30,767株 | -48.15% | 103,897株 | -0.95% | 18,400株 | -46.32% |
2022/08/26 | 日証協 | 98,812株 | +24.86% | 59,342株 | +76.34% | 104,897株 | +10.16% | 34,280株 | +39.91% |
2022/08/19 | 日証協 | 79,138株 | -4.7% | 33,652株 | +15.8% | 95,223株 | -8.37% | 24,501株 | +44.86% |
2022/08/12 | 日証協 | 83,038株 | -8.18% | 29,061株 | -43.9% | 103,919株 | -10.96% | 16,913株 | -47.19% |
2022/08/05 | 日証協 | 90,438株 | +27.3% | 51,800株 | -36.81% | 116,709株 | +3% | 32,024株 | +28.95% |
2022/07/29 | 日証協 | 71,044株 | +20.73% | 81,977株 | +15.14% | 113,307株 | +11.81% | 24,835株 | +2.16% |
2022/07/22 | 日証協 | 58,843株 | -26.76% | 71,200株 | +14.85% | 101,337株 | -17.03% | 24,309株 | -8.96% |
2022/07/15 | 日証協 | 80,343株 | -6.95% | 61,996株 | +782.51% | 122,141株 | -7.66% | 26,700株 | +66.64% |
2022/07/08 | 日証協 | 86,343株 | +0.03% | 7,025株 | -84.01% | 132,269株 | +4.33% | 16,023株 | -21.93% |
2022/07/01 | 日証協 | 86,318株 | +10.88% | 43,926株 | +54.36% | 126,780株 | +0.08% | 20,523株 | +4.18% |
2022/06/24 | 日証協 | 77,848株 | -3.41% | 28,457株 | -26.8% | 126,680株 | -3.39% | 19,700株 | -13.81% |
2022/06/17 | 日証協 | 80,598株 | -3.47% | 38,874株 | +55.72% | 131,124株 | -8.11% | 22,856株 | -1.06% |
2022/06/10 | 日証協 | 83,492株 | -30.6% | 24,964株 | -79.51% | 142,689株 | -14.31% | 23,102株 | -83.96% |
2022/06/03 | 日証協 | 120,298株 | +54.41% | 121,840株 | +661.5% | 166,522株 | -39.39% | 144,028株 | -0.52% |
2022/05/27 | 日証協 | 77,906株 | -0.22% | 16,000株 | -80.49% | 274,727株 | +155.43% | 144,777株 | +79.62% |
2022/05/20 | 日証協 | 78,078株 | +52.07% | 82,006株 | +338.42% | 107,553株 | +50.79% | 80,600株 | +274.05% |
2022/05/13 | 日証協 | 51,343株 | -50.43% | 18,705株 | +172.23% | 71,326株 | -35.38% | 21,548株 | +124.27% |
※株式分割は考慮していませんのでご注意ください。
Page Top